Yale Cancer Center 2015 Rausch Pilot Research Grant from The Edith P. Rausch Fund of The Community Foundation for Greater New Haven
To provide seed money to members of Yale Cancer Center (YCC) to enable
investigators to engage in innovative cancer research, with the goal of facilitating new research on the fundamental causes of, or an effective cure for, cancer. We anticipate funding two to three pilot grants. Priorities for the pilot grants include studying and/or ameliorating sociodemographic disparities in cancer incidence or outcomes; the prevention and/or treatment of women’s cancers, as well as neighborhood/urban or other community factors that contribute to cancer etiology. Preference will be given to research that has a high likelihood of having a demonstrable community impact in the Greater New Haven area.
YCC members or faculty who have applied for membership are eligible to serve as P.I. Grants are not intended to supplement on-going studies or provide bridge funding. Recipients of a pilot award are eligible to apply for a subsequent one-year funded extension which will be judged in the competition with new applications. A P.I. may submit only a single pilot research grant proposal for this competition. Up to $30,800 for one year commencing October 1, 2015.
Application Deadline: August 13, 2015 at 4PM
Class of ’61 Yale Cancer Research Award
YCCI Scholar Awards
We are pleased to announce a request for applications for YCCI Scholar Awards, which provide salary and/or research funds to a select number of junior faculty members who are strongly committed to careers in clinical research, community‐based research or translational research. Individuals must be nominated by a department chair, division head/section chief, or center/program director. The primary aim of these awards are to prepare the applicant for successful independent research careers, and emphasis will be placed on career development and mentoring plans. Awards will be for a total of 2 years. Funds can be requested to cover up to 75% of an individual’s salary (with a maximum of $100,000 including fringe benefits per year) and up to $20,000 of research support per year for a clinical community, or translational research project. Applicants who already have either a career development award or a substantial Departmental start‐up package may submit an application for up to $20,000 in research support per year, but this must be for a separate (though possibly related) project from the one supported by the career development award/start‐up package.
Due date for letters of intent: July 24, 2015 at 5:00 PM
AACR-Genentech BioOncology Career Development Award for Cancer Research on the HER Family Pathway
The AACR-Genentech BioOncology Career Development Award for Cancer Research on the HER Family Pathway represents a joint effort to encourage and support a physician-scientist to conduct cancer research on the HER Family Pathway and to establish a successful career path in this field. Eligibility is limited to junior faculty-level physician-scientists who, at the start of the grant term, will have completed their most recent medical residency or doctoral degree within the past 11 years.
Application Deadline: July 22, 2015
AACR NextGen Grants for Transformative Cancer Research
These three-year grants of $450,000 represent a new AACR funding initiative to stimulate highly innovative research from young investigators. Eligibility is limited to junior faculty who have held a full-time, tenure-track appointment as an assistant professor for no more than three years.
Letter of Intent Deadline: August 10, 2015
Provocative Questions in Cancer with an Underlying HIV Infection (R01)
The purpose of this funding opportunity announcement (FOA) is to advance our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying HIV infection or Acquired Immune Deficiency Syndrome (AIDS) through research directed at addressing one of several proposed "Provocative Questions" (PQs). These PQs are not intended to represent the full range of NCI's priorities in HIV/AIDS-related cancer research. Rather, they are meant to challenge researchers to think about and elucidate specific problems and paradoxes in key areas of AIDS-related cancer research that are deemed important but have not received sufficient attention.
Application Deadline: August 18, 2015
Assay Validation For High Quality Markers For NCI-Supported Clinical Trials
The purpose of this Funding Opportunity Announcement (FOA) is to improve the development and validation of molecular diagnostics for the treatment, control, or prevention of cancer. This FOA includes, but is not limited to, the validation of prognostic, predictive or response markers for treatment and markers for cancer control or prevention trials. Applicants should have an assay that works in human samples and whose importance is well justified for development into a clinical assay. In addition, analytical validation of assays for these markers should be achieved when the application is submitted so that clinical validation may be achieved with little further analytical validation needed. This supplement may be used to support acquisition of specimens from retrospective or prospective studies from NCI-supported or other clinical trials. Clinical laboratory staff, technical and other needs must be an integral part of the application. Assays proposed for this FOA may be used to validate existing assays for use in other cancer clinical trials, observational studies or populations. Projects proposed for this FOA will require multi-disciplinary interaction and collaboration among scientific investigators, clinicians, statisticians and clinical laboratory scientists and staff. This FOA is not intended to support trials that assess the clinical utility of a marker/assay but is intended to develop assays to the point where their clinical utility could be assessed in other trials.
Application Deadline: October 7, 2015
Smoking Cessation within the Context of Lung Cancer Screening
The goal of this Funding Opportunity Announcement (FOA) is to improve the effectiveness and/or implementation of smoking cessation interventions delivered to current smokers who undergo low-dose computed tomography (LDCT) lung cancer screening. The proposed projects must be aimed at determining:
a) the key components and characteristics of an effective smoking cessation intervention delivered in the LDCT setting; and/or
b) characteristics of an implementation strategy to optimally incorporate existing evidence-based smoking cessation intervention(s) into the LDCT setting.
Application Deadline: October 8, 2015
In order to recognize significant accomplishment and continuing outstanding promise in cancer research, Yale Cancer Center is pleased to announce the Class of ’61 Yale Cancer Research Award. This annual award recognizes significant accomplishment in cancer research at Yale University by a young member of the faculty, coupled with the expectation for future outstanding contributions to our understanding of the causes and cures for cancer. The annual award, established through the ongoing generosity of the Yale College Class of 1961, will provide unrestricted funds to support the winner’s cancer research. The initial award will be $50,000. Nominees must be Yale faculty members age 45 or less, whose accomplishments are documented by published papers and awarded grants in any area of cancer research including seminal investigations into basic cancer biology, important translational or clinical studies, or critical population science studies. Nomination guidelines and further information can be obtained from
Deadline for nominations:
August 31, 2015
Yale Discovery Fund Grants
To support exceptionally innovative or unconventional collaborative cancer research at Yale Cancer Center with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies.
In order for Yale Cancer Center to reach its potential as one of the nation’s top cancer centers, it has to conduct research with the potential to transform our understanding of the causes of cancer or to revolutionize our ability to study, prevent, treat, or cure cancer. Such research is intrinsically high-risk and is unlikely to fare well in review in the current conservative NIH funding environment. In addition, such research will often require the assembly of collaborative multidisciplinary teams that bring different perspectives to a complex problem. To stimulate collaborative high-impact cancer research, the YCC is establishing the Yale Discovery Fund grant program. These grants will provide relatively long-term, generous support to allow teams of investigators to embark on ground-breaking, innovative high-risk/high-reward cancer research. These grants will be supported by the venture philanthropy model, in which they will be funded primarily by substantial gifts from a limited number of donors who will play an active role in the selection of successful applications and will be regularly appraised of progress. Our goal is that the research supported by these grants will be transformative: it will create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. In addition, we hope that teams not selected for funding will continue to meet and collaborate and refine their proposals for submission to other internal and external grant competitions.
Letter of Intent Due- July 8, 2015
National Comprehensive Cancer Network (NCCN) and Pfizer Independent Grants for Learning & Change (IGLC) Metastatic Breast Cancer Request for Proposals
Pfizer and the National Comprehensive Cancer Network (NCCN) are collaborating to offer a new grant opportunity focused on improving care for patients with metastatic breast cancer (MBC), where treatment goals focus on improving quality and length of life as there is, to date, no known cure. Multiple factors contribute to the complexity of treating the disease, including the rapidly changing options for personalizing treatment strategies, managing treatment and disease side effects, communicating with patients, caregivers and family members about quality of life and end-of-life decisions, as well as the many obstacles patients face when living with the disease.
The intent of the RFP is to encourage organizations to submit letters of intent (LOIs) describing concepts and ideas for design and implementation of programs that close clinical practice gaps and improve the quality of care for patients with MBC through increased competence and performance of health care providers and health care systems.
Letters of Intent due - July 15, 2015
Patterson Trust Fellowship Program in Clinical Research
The Robert E. Leet and Clara Guthrie Patterson Trust was established in 1980 for the advancement of medical science, particularly research "relating to human diseases, their causes and relief." Two-year fellowships of $90,000 ($45,000 per year) will be awarded to Applicants working in Connecticut or New Jersey.
The Patterson Trust will provide support to early-stage mentored investigators conducting clinical research with a focus on patient-oriented or translational laboratory research. The Program will help the Trust to pursue its mission by providing Applicants with the opportunity to demonstrate creativity and explore opportunities that may promote careers in clinical research. Pilot and preliminary studies are encouraged.
Application Deadline: August 14, 2015
Simons Foundation Faculty Scholars Competition
The Simons Foundation, Howard Hughes Medical Institute (HHMI) and the Bill & Melinda Gates Foundation are pleased to announce the Faculty Scholars Competition, a national competition for grants to outstanding early-career scientists.
The three philanthropies will award a total of $148 million over the program's first five years, awarding up to 70 grants every two and a half to three years. The awards are intended for basic researchers and physician scientists who have already demonstrated significant research accomplishments and show potential to make unique and important contributions to their fields.
The Faculty Scholars Competition marks the first time that HHMI, the Bill & Melinda Gates Foundation and the Simons Foundation have formally undertaken an initiative together.
Application Deadline: July 28, 2015
YCC/SCH Grants for Small Projects to Improve Patient Care
Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven are pleased to announce a new program to fund small projects to improve patient care at Smilow Cancer Hospital. Monies for this program have come through our “Closer to Free” fund. Any employee at Smilow Cancer Hospital who develops a small project may apply by submitting an application for review. Projects can range from a patient education program to stress management for staff. In order to be eligible, the employee must be sponsored by a current Cancer Center Member. A listing of active cancer center members is on the web site.
Amount: $2,500 to $5,000 each
Eligibility: Employees of Smilow Cancer Hospital at Yale-New Haven
Sponsorship: Member of Yale Cancer Center
Application: Limited to 3 pages, typed, double spaced; plus budget with justification (3 copies)
- Application sheet: Project Due Date
- Project Description
- Budget Justification
Submit to Renee Gaudette: email@example.com
For questions, contact Dr. Ruth McCorkle by email: firstname.lastname@example.org
Breast Cancer Alliance (BCA) Announces three Grant Opportunities for 2016
The mission of the BCA is to improve survival rates and quality of life for those impacted by breast cancer through prevention, early detection, treatment and cure. To promote these goals, we invest in innovative research, breast surgery fellowships, regional education, dignified support and screening for the underserved.
Exceptional Project Grant:
The Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers whose primary focus is breast cancer to apply for an Exceptional Project Grant. The award recognizes creative, unique, and innovative research and is open to applicants at institutions within a 200-mile radius of Greenwich, CT. This is a one-year grant for a total of $100,000. Prior to submission of a formal grant proposal, the BCA requires a one-page Letter of Intent (LOI) and a separate CV. For 2015 grants, those letters will be due on April 2, 2015. The LOI must include the applicant’s name, job title, and institution at the top of the page, and the applicant’s contact information. The document should state the project title and hypothesis, outline the research aim(s) and methods, and include a brief discussion of the project’s potential impact. The CV can be in the NIH biosketch format and should be no more than four pages long. Applicants will be informed by the first week of May 2015 whether they have been invited to proceed with a formal application. Researchers should coordinate with their institutions, as the BCA will accept a maximum of three LOIs per institution. (Full proposals, if invited, will be due on or before July 24, 2015.)
Young Investigator Grants: Note: No limit on the number of submissions per institution.
To encourage a commitment to breast cancer research, the Breast Cancer Alliance invites clinical doctors and research scientists whose primary focus is breast cancer and who are in the early stages of their careers to apply for funding for the Young Investigator Grant. This grant is open to applicants at institutions within a 200-mile radius of Greenwich, CT. This is a two-year grant for a total of $125,000, with half the grant award being paid out each year.
Applicants for 2016 grants much (i) have held a faculty position for no more than four years following the completion of their training, as of February 1, 2015; (ii) have not been a principal investigator on an NIH R01 or equivalent national/international non-mentored award; and (iii) dedicate at least 50% of their work effort to research. This grant is intended to help advance the careers of young researchers who do not yet have their own major grant support. Grant applications are due on or before July 24, 2015. An independent External Review Committee reviews and evaluates the applications. Based on their results and subsequent review by the Grants Committee, recommendations will be made to the BCA Board for final approval. Applicants will be notified in mid-December of the decision regarding their proposals. To download an application, click here: 2016-YIG-application For questions about any research grants, please e-mail: email@example.com
Education and Outreach Grants:
The Breast Cancer Alliance offers grants to support programs directly related to outreach and case managerial breast cancer services, including education, counseling, and mammograms for the uninsured/underserved. The programs must be located in Connecticut and/or Westchester County, New York. This is a one-year grant.
For 2016 grants, final applications are due on or before July 31, 2015. The Grants Committee of the Breast Cancer Alliance reviews and evaluates each grant proposal. The results of the Grants Committee’s evaluations and subsequent recommendations are presented to the BCA Board for approval. Applicants are notified in mid-December of the decision regarding their proposals. To download the final report form for 2014 grants, click here for the 2014 Final Report
For questions about any education and outreach grants please email: firstname.lastname@example.org